Huizenga Theodore Alan 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Apr 18, 2024
Insider Transaction Report
Form 4
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-04-16$42.31/sh−14$592→ 41,366 total
Footnotes (2)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.